home / stock / tffp / tffp news


TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 05/15/20

Stock Information

Company Name: TFF Pharmaceuticals Inc - Ordinary Shares
Stock Symbol: TFFP
Market: NASDAQ
Website: tffpharma.com

Menu

TFFP TFFP Quote TFFP Short TFFP News TFFP Articles TFFP Message Board
Get TFFP Alerts

News, Short Squeeze, Breakout and More Instantly...

TFFP - TFF Pharmaceuticals, Inc. 2020 Q1 - Results - Earnings Call Presentation

The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with their 2020 Q1 earnings Read more ...

TFFP - TFF Pharmaceuticals' (TFFP) CEO Glenn Mattes on Q1 2020 Results - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (TFFP) Q1 2020 Earnings Conference Call May 14, 2020 5:00 PM ET Company Participants Paul Sagan – Investor Relations Glenn Mattes – President and Chief Executive Officer Kirk Coleman – Chief Financial Officer Chris Cano – Vi...

TFFP - TFF Pharmaceuticals EPS beats by $0.04

TFF Pharmaceuticals (NASDAQ: TFFP ): Q1 GAAP EPS of -$0.20 beats by $0.04 . Cash and cash equivalents of $25.73M Press Release More news on: TFF Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,

TFFP - TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

Maintains clinical progress with lead programs, Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder Thin Film Freezing platform technology employed in numerous partnership programs for vaccine and anti-viral applications Conference call and live webcast scheduled for T...

TFFP - TFF Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 14, 2020

Company to hold conference call and webcast at 5:00 PM EDT TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today a...

TFFP - TFF Pharmaceuticals' Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting

Data presented on repurposing the existing, broad-spectrum antiviral agent using Thin Film Freezing and other techniques to enhance its effect for COVID-19 therapy TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercial...

TFFP - TFF Pharmaceuticals (TFFP) Presents At Virtual Investor Summit - Slideshow

The following slide deck was published by TFF Pharmaceuticals, Inc. in conjunction with this Read more ...

TFFP - U.S. IPO Week Ahead: Another Quiet Week For The IPO Market With 1 Biotech

One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, plans to raise $75 million at a $424 million market cap. The...

TFFP - U.S. IPO Weekly Recap And Week Ahead

There were no IPOs this past week, but initial filings from a biotech and a Chinese issuer are keeping the IPO market moving. After another strong week, the IPO Index is now up about 35% from its March lows. As we pointed out in our 1Q20 IPO Review, the first IPOs to emerge from the shutdown...

TFFP - TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit

Corporate presentation and live webcast scheduled for April 22, 2020 at 10:00am ET TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) tech...

Previous 10 Next 10